Repsly Announces New Retail Technology Partnership with Curaleaf

Repsly a best-in-class retail technology platform, today announced it has entered into a technology partnership agreement with Curaleaf (CSE: CURA OTCQX: CURLF), a leading international provider of consumer products in cannabis. This agreement will support Curaleaf's wholesale operations across the US by providing CRM solutions, retail execution support, and business analytics and insights to the Curaleaf teams.

With 125 dispensaries in 23 U.S. states, Curaleaf is one of the largest vertically integrated cannabis companies. Curaleaf chose Repsly after realizing a need to enhance their technology stack in support of their quickly expanding go-to-market needs within North America .

"With Repsly's powerful operational platform and their Insights Dashboard business intelligence solution, we'll be able to assess our wholesale execution plans with real-time and trended data on sales performance, promotion execution and more. These data-driven insights will allow our team to learn and pivot on a dime as feedback comes in from their field," said Patrick Larkin , SVP of Sales at Curaleaf.

"Our team at Repsly is obsessed with helping our customers win by executing perfectly at all aspects of retail, every day," said Matthew Brogie , CEO at Repsly. "Knowing that we have the opportunity to help Curaleaf navigate competitively in one of the fastest growing consumer industries, and that we can support Curaleaf and their portfolio of brands in their next generation plans is extremely energizing for our team! We're looking forward to rolling up our sleeves and working hard to demonstrate that Repsly is the right partner to support Curaleaf in this amazing growth journey."

Curaleaf will begin to roll out the Repsly platform in February 2022 .

About Repsly
Repsly, Inc. is a retail execution software that empowers CPG teams to make data-driven insights and achieve peak performance in the field. Repsly helps global brands like Kraft Heinz, Adidas, L'Oreal, Spindrift, Beyond Meat, Mattel, and AB InBev control compliance at the brand level, improve coverage at the territory level, and execute at the store level. Repsly is the only retail execution solution to connect store-level activities with their impact on sales. Headquartered in Boston, MA with offices globally, Repsly works with over 800 brands in 80 countries around the world.

About Curaleaf
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) ("Curaleaf") is a leading international provider of consumer products in cannabis with a mission to improve lives by providing clarity around cannabis and confidence around consumption. As a high-growth cannabis company known for quality, expertise and reliability, the Company and its brands, including Curaleaf and Select, provide industry-leading service, product selection and accessibility across the medical and adult-use markets. In the United States , Curaleaf currently operates in 23 states with 125 dispensaries, 25 cultivation sites, and employs over 5,200 team members. Curaleaf International is the largest vertically integrated cannabis company in Europe with a unique supply and distribution network throughout the European market, bringing together pioneering science and research with cutting-edge cultivation, extraction and production. Curaleaf is listed on the Canadian Securities Exchange under the symbol CURA and trades on the OTCQX market under the symbol CURLF. For more information, please visit https://ir.curaleaf.com.

Media enquiries to:
Cait Will ( cait.will@repsly.com )
Stephanie Pojatina ( stephanie.pojatina@repsly.com )

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/repsly-announces-new-retail-technology-partnership-with-curaleaf-301473778.html

SOURCE Repsly Inc.

Cision View original content to download multimedia: https://www.newswire.ca/en/releases/archive/February2022/02/c9108.html

News Provided by Canada Newswire via QuoteMedia

CURA:CNX,CURLF
The Conversation (0)
Cannabis business with marijuana leaves and stock

Cannabis Market 2025 Year-End Review

2025 marked a turning point for investment in the cannabis sector, shifting the focus toward operational resilience and consolidation after a sluggish 2024. Key market drivers included an upswing in merger and acquisition (M&A) activity as stronger multi-state operators (MSOs) acquired... Keep Reading...
Cannabis plant with green leaves and buds on a dark green background.

Cannabis Market Forecast: Top Trends for Cannabis in 2026

The US cannabis market is entering 2026 with brighter prospects after a punishing few years marked by stalled rescheduling efforts, price compression, retail saturation and slow state expansion.Now, however, regulatory tailwinds seeming aligned for a potential re-rating.On December 18, US... Keep Reading...
Cannabis plant in focus, blurred US flag background.

Analysts React: Trump Signs Executive Order to Reschedule Cannabis

The long-debated issue of US cannabis rescheduling is finally back in the spotlight. On Thursday (December 18), President Donald Trump signed an executive order to expedite the process of moving cannabis from Schedule I to Schedule III under the Controlled Substances Act. Market watchers are now... Keep Reading...
Close-up of green cannabis leaves in natural light.

Trump Weighs Executive Order to Loosen Federal Cannabis Restrictions

US President Donald Trump is reportedly weighing a major shift in federal drug policy that would relax decades-old restrictions on cannabis, potentially injecting new life into the industry. Six people familiar with the discussions told the Washington Post that Trump is preparing an executive... Keep Reading...
Gavel on a surface with scattered cannabis leaves, symbolizing legal issues around marijuana.

Hemp THC Recriminalization: A Blow to a Blooming Industry

A spending bill to reopen the US government after a 43 day shutdown includes provisions that will recriminalize most hemp-derived THC products. This change, slated to become effective one year after enactment, in late 2026, marks a significant policy reversal from the 2018 Farm Bill, which... Keep Reading...
Cannabis buds on a wooden surface with Australian banknotes nearby.

Australia's Cannabis Import Quota Slashed Amid Surging Local Production

Australia’s Office of Drug Control (ODC) said the country’s 2025 cannabis import quota has been reduced by the International Narcotics Control Board from 101 tonnes to 88 tonnes, Business of Cannabis reported.Over-projected demand and idle permits that limited operational flexibility were cited... Keep Reading...

Interactive Chart

Latest Press Releases

Related News